<unk>  refers to a regimen consisting of velcade (bortezomib), rituximab, cyclophosphamide, hydroxydaunorubicin (doxorubicin), oncovin (Vincristine), prednisone used to treat previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
.
VR-CHOP regimen
LR-CHOP-21 regimen
CBV regimen
DBVE-PC regimen
CyBorD regimen
TAC regimen
R-CDOP regimen
ICE-R regimen